BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24839854)

  • 21. [Discussion about Supervision Model of Customized Medical Device].
    Sun J; Wu J; Qian H; Liu B; Zhang S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Nov; 41(6):432-435. PubMed ID: 29862704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pivotal medical-device case.
    Picca SM
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426011
    [No Abstract]   [Full Text] [Related]  

  • 23. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial requests of indigenous diagnostic imaging ultrasound devices in first-time registration application].
    Guo Z; Cao G; Tao K
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Nov; 36(6):438-40. PubMed ID: 23461122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Jan; 79(7):1735-41. PubMed ID: 24409553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical devices; medical device reporting; baseline reports. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of the regulations on medical devices in the European Union.
    Frank S
    Food Drug Law J; 2001; 56(1):99-122. PubMed ID: 11942353
    [No Abstract]   [Full Text] [Related]  

  • 30. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Approval Status and Suggestions on Supervision of Class II Innovative Medical Device].
    Duan S; Zhong Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Jan; 47(1):80-82. PubMed ID: 36752012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical device registration system comparison between China and U.S.A].
    Yue W
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Jan; 33(1):51-8. PubMed ID: 19459353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical innovations in the area of conflict between certification and allowance].
    Möller B; Stockheim M; Kraus T; Weber A
    Dtsch Med Wochenschr; 2010 Oct; 135(42):2088-92. PubMed ID: 20941684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Canadian perspective: trends in drug and medical device class actions in Canada.
    Vernon W
    Food Drug Law J; 2006; 61(3):569-76. PubMed ID: 16989040
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approval of an alternative requirement of the Mammography Quality Standards Act; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60352. PubMed ID: 10187394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pivotal medical-device case.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule.
    Fed Regist; 1998 Oct; 63(195):54042-4. PubMed ID: 10185825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical device regulations and testing for toxicologic pathologists.
    Schuh JC
    Toxicol Pathol; 2008 Jan; 36(1):63-9. PubMed ID: 18337222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.